Experiments on the mode infection in epidemie meningitis. 1 Exp Med, pp.605-618, 1919. ,
Lipopolysaccharide heterogeneity and escape mechanisms ofNeisseria meningitidis: possible consequences for vaccine development, Microbial Pathogenesis, vol.23, issue.3, pp.139-155, 1997. ,
DOI : 10.1006/mpat.1997.0143
Meningococcal disease in Spain, Eurosurveillance Weekly, vol.1, issue.1, 1997. ,
Vaccination programme for group C meningococcal infection is launched in the United Kingdom, Eurosurveillance Weekly, vol.3, issue.30, 1999. ,
Efficacy of meningococcal serogroup C conjugate vaccine in England, Eurosurveillance Weekly, vol.5, issue.5, 2001. ,
Emergence de la méningococcie W135, rapport d'une consultation de l'OMS, 2001. ,
Surveillance of bacterial meningitis in Europe, Eurosurveillance Weekly, vol.6, issue.15, 1999. ,
OMS (Organisation Mondiale de la Santé), Aide mémoire, 2003. ,
Situation épidémiologique des méningites à méningocoques dans le département de Seine Maritime et dans la zone de Dieppe au 19 Février, 2006. ,
Niger: une épidémie de méningite devastatrice, Sciences Sud, 2000. ,
Eradication Of Nasopharyngeal Carriage Of Neisseria Meningitidis In Children And Adults In Rural Africa: A Comparison Of Ciprofloxacin And Rifampicin, Journal of Infectious Diseases, vol.171, issue.3, pp.728-731, 1995. ,
DOI : 10.1093/infdis/171.3.728
Méningite à méningocoque: les traitements actuels, Les actualités pharmaceutiques, p.408, 2002. ,
The meningococcus and mechanisms ofpathogenicity, Microbiol Rev, vol.46, p.162, 0190. ,
Impact d'une campagne de vaccination de masse contre le méningocoque de sérogroupe C dans la province de Québec, pp.407-411, 1996. ,
Spread of penicillin producing and transfer plasmids from gonococcus to Neisseria meningitidis, Lancet, pp.779-781, 1983. ,
The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells, FEMS Immunology & Medical Microbiology, vol.22, issue.Suppl. 10, pp.27-36, 1999. ,
DOI : 10.1007/978-94-009-5863-0_9
Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of Serotypes, Clinical Infectious Diseases, vol.7, issue.4, pp.504-510, 1985. ,
DOI : 10.1093/clinids/7.4.504
Dexamethasone treatment for bacterial meningitis in children and adults, The Pediatric Infectious Disease Journal, vol.8, issue.12, pp.848-851, 1989. ,
DOI : 10.1097/00006454-198912000-00004
Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children, Journal of Infectious Diseases, vol.140, issue.5, pp.690-697, 1979. ,
DOI : 10.1093/infdis/140.5.690
HUMAN IMMUNITY TO THE MENINGOCOCCUS: III. PREPARATION AND IMMUNOCHEMICAL PROPERTIES OF THE GROUP A, GROUP B, AND GROUP C MENINGOCOCCAL POLYSACCHARIDES, Journal of Experimental Medicine, vol.129, issue.6, pp.1349-1366, 1969. ,
DOI : 10.1084/jem.129.6.1349
Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit., Journal of Clinical Investigation, vol.93, issue.3, pp.929-936, 1994. ,
DOI : 10.1172/JCI117098
Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease, Vaccine, vol.21, issue.7-8, pp.734-73, 2003. ,
DOI : 10.1016/S0264-410X(02)00591-1
Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatries, pp.161-167, 1989. ,
Meningococcal vaccines, 1994. Vaccines, second edition, pp.503-515, 1994. ,
Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat., Journal of Clinical Investigation, vol.82, issue.1, pp.102-109, 1988. ,
DOI : 10.1172/JCI113556
Quatresous 1. Campagne de vaccination suite à l'augmentation de l'incidence de l'infection à méningocoque du groupe C dans le département du Puy-de-Dôme, Eurosurveillance, issue.5, pp.7-74, 2002. ,
Meningococcal Meningitis in Sub-Saharan Africa: A Model for the Epidemic Process, Clinical Infectious Diseases, vol.14, issue.2, pp.515-525, 1992. ,
DOI : 10.1093/clinids/14.2.515
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil, The Lancet, vol.340, issue.8827, pp.1074-1078, 1992. ,
DOI : 10.1016/0140-6736(92)93086-3
Induction of Meningeal Inflammation by Outer Membrane Vesicles of Haemophilus influenzae Type b, Journal of Infectious Diseases, vol.159, issue.5, pp.917-922, 1989. ,
DOI : 10.1093/infdis/159.5.917
Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis., Journal of Clinical Investigation, vol.84, issue.4, pp.1253-1259, 1989. ,
DOI : 10.1172/JCI114292
URL : http://www.jci.org/articles/view/114292/files/pdf
Tumour necrosis factor alpha antibody protects against lethal meningococcaemia, Molecular Microbiology, vol.145, issue.5, pp.591-597, 1992. ,
DOI : 10.1084/jem.170.6.1859
Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells ,
Febrile seizures after immunisation with meningococcal A+C vaccine, Ped Infect Dis J, vol.8, pp.250-251, 1989. ,
Haemophilus influenzae Lipopolysaccharide Disrupts Confluent Monolayers of Bovine Brain Endothelial Cells via a Serum-Dependent Cytotoxic Pathway, Journal of Infectious Diseases, vol.165, issue.5, pp.865-872, 1992. ,
DOI : 10.1093/infdis/165.5.865
Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age, New England Journal of Medicine, vol.297, issue.13, pp.686-691, 1977. ,
DOI : 10.1056/NEJM197709292971302
Meningococcal Vaccines, Drugs, vol.55, issue.3, pp.347-366, 1998. ,
DOI : 10.2165/00003495-199855030-00003
Argumentaire concernant la prophylaxie antiméningococcique élargie dans le quartier de Borny, 2003. ,
Les infections invasives à méningocoques en France en, BEH (Bulletin Epidémiologique Hebdomadaire), vol.046, 2003. ,
Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation., Journal of Clinical Investigation, vol.77, issue.4, pp.1084-1095, 1986. ,
DOI : 10.1172/JCI112407
Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor., Journal of Clinical Investigation, vol.87, issue.4, pp.1360-1366, 1991. ,
DOI : 10.1172/JCI115140
Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation, Journal of Experimental Medicine, vol.172, issue.2, pp.497-507, 1990. ,
DOI : 10.1084/jem.172.2.497
Methodes de laboratoire: Neisseria et Branhamella, Institut Pasteur, 1993. ,
Centre National de Référence des Méningocoques et Neisseria apparentés. Unité des Neisseria, 1994. ,
Incidence of reactions to meningococcal A&C vaccine among U.K. schoolchildren, Public Health, vol.102, issue.5, pp.471-476, 1988. ,
DOI : 10.1016/S0033-3506(88)80085-4
Human antibody reponse to meningococcal outer membrane antigens after three dose of the Norwegian group B meningococcal vaccine, Infect Immun, vol.63, pp.4642-4652, 1995. ,
Antiinflammatory Effects in Experimental Meningitis of Prokaryotic Peptides that Mimic Selectins, Journal of Infectious Diseases, vol.168, issue.6, pp.1422-1428, 1993. ,
DOI : 10.1093/infdis/168.6.1422
SUMMARY, Epidemiology and Infection, vol.23, issue.02, pp.463-469, 1987. ,
DOI : 10.1056/NEJM196502252720804
The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis, Journal of Experimental Medicine, vol.171, issue.2, pp.439-448, 1990. ,
DOI : 10.1084/jem.171.2.439
Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species, Journal of Molecular Evolution, vol.34, issue.2, pp.115-125, 1992. ,
DOI : 10.1007/BF00182388
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm, Cell, vol.76, issue.2, pp.301-314, 1994. ,
DOI : 10.1016/0092-8674(94)90337-9
Thymus-Independent and Thymus-Dependent Responses to Polysaccharide Antigens, Journal of Infectious Diseases, vol.165, issue.Supplement 1, pp.49-52, 1992. ,
DOI : 10.1093/infdis/165-Supplement_1-S49
Dexamethasone Therapy for Bacterial Meningitis in Children: 2- versus 4-Day Regimen, Journal of Infectious Diseases, vol.169, issue.4, pp.853-858, 1994. ,
DOI : 10.1093/infdis/169.4.853
Pilus-mediated adhesion of Neisseria meningitidis: the essential role of cell contact-dependent transcriptional upregulation of the PilC1 protein, Molecular Microbiology, vol.273, issue.6, pp.1153-1163, 1998. ,
DOI : 10.1126/science.273.5279.1234
Immunogenicity of two serogroup B outer membrane protein meningococcal vaccines: a randomized controlled trial in Chile, Jama, vol.281, pp.1520-1527, 1999. ,
Prevention of group B meningococcal disease by vaccination: a difficult task, J Med, p.117, 2004. ,
Meningococcal disease: public health burden and control, World Health Stat Q, vol.50, pp.170-177, 1997. ,
Lutte contre les épidémies de méningite à méningocoque. Guide pratique de l'OMS (Organisation Mondiale de la Santé), 1998. ,
Effectiveness ofmeningococcal serogroup C conjugate vaccine 4 years after introduction, Lancet, vol.7, pp.364-365, 2004. ,
DOI : 10.1016/s0140-6736(04)16725-1
Blood-brain barrier alterations in bacterial meningitis: Development of an in vitro model and observations on the effects of lipopolysaccharide, In Vitro Cellular & Developmental Biology - Animal, vol.82, issue.2, pp.113-120, 1991. ,
DOI : 10.7326/0003-4819-112-8-610
Dictionnaire des médicaments, 2006. ,
Adverse events temporally associated with meningococcal vaccines, Can Med Assoc J, vol.154, pp.503-507, 1996. ,
vvvvvv.churouen . fr/cap/meningo.html Site « Méningite info » : wwvv.mcningite.info/repartition/afrique.html Site de l'OMS (Organisation Mondiale de la Santé) : www.who ,